Furthermore, we found that the methylation status of tested genes in tumor tissue could be used as a potential prognostic biomarker in patients with early-stage NSCLC because hypomethylation of specific CpG sites in ASC/TMS1/PYCARD gene was associated with reduced overall survival. The gene discussed is PYCARD; the disease is non-small cell lung carcinoma.